SCHEMBL4665181

SCHEMBL4665181

CCC(C(=O)O)C(C)c1ccc(OCCOC)cc1Oc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 17/20 0.55
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3202753 0.85 PPARG (0.58) PPARGLMNASMN1; SMN2
SCHEMBL3216914 0.83 PPARG (0.57) PPARGLMNASMN1; SMN2
SCHEMBL4665185 0.82 PPARG (0.56) PPARGLMNASMN1; SMN2
SCHEMBL3195489 0.81 PPARG (0.70) PPARGLMNASMN1; SMN2
SCHEMBL3209515 0.81 PPARG (0.53) PPARGLMNASMN1; SMN2
SCHEMBL4666566 0.81 PPARG (0.55) PPARGLMNASMN1; SMN2
SCHEMBL3207338 0.79 PPARG (0.70) PPARGLMNASMN1; SMN2
SCHEMBL4601627 0.79 PPARG (0.53) PPARGLMNASMN1; SMN2
SCHEMBL4529256 0.78 PPARG (0.53) PPARGLMNASMN1; SMN2
SCHEMBL4666563 0.78 PPARG (0.61) PPARGLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed